Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 16714-534

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 16714-534). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

122 (Emtricitabine And Tenofovir Disoproxil Fumrate Label)

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg film-coated oral tablets, containing 30 tablets per bottle. Manufactured for NorthStar Rx LLC and by Macleods Pharmaceuticals Ltd., India. The label includes dosage strength, pharmacist dispensing instructions, storage conditions, and contact information for medication guides.*

FDA Label Image

123 (Structure Emtricitabine)

Chemical structure of tenofovir disoproxil fumarate, showing the arrangement of atoms including nitrogen, oxygen, sulfur, fluorine, and carbon in the molecule.*

FDA Label Image

134 (Structure Tenofovir)

Chemical structure diagram of emtricitabine and tenofovir disoproxil fumarate displayed as molecular formulas with atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.